Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
MBCs mature over time after SARS-CoV-2 infection or mRNA vaccination (34–39). We recently showed that an AS03, a squalene oil-in-water emulsion adjuvant developed by GlaxoSmithKline, -adjuvanted nanoparticle vaccine conferred durable and heterotypic protection against Omicron challenge with 100% and about 65% protection at 6 weeks and 6 months after the booster, respectively (11). The rapid elicitation of bnAbs in serum after the booster suggested the evolution of a broad and potent antibody repertoire encoded in the MBC compartment. Consistent with this notion, we found in this study that SHMs and the potency and breadth of antibodies encoded by B cell receptors in MBCs evolved after the primary vaccination. Those matured MBCs with greater potency and breadth can rapidly differentiate into antibody-secreting cells in response to a booster immunization or infection. Although it is well known that adjuvants can modulate and enhance the magnitude, breadth, and durability of the vaccine-induced serum antibody response, few studies have investigated their effects on the monoclonal level (28, 40–46). In this study, we found that the primary vaccination of the AS03-adjuvanted nanoparticle–based subunit vaccine elicited a progressive antibody evolution toward greater potency and breadth over a period of 1 year, presumably driven by antigen-antibody complexes on follicular dendritic cells.
To meet the study’s definition of long covid, a participant needed to score a total of 12 points once all their symptoms were added up. The 12 key symptoms and their corresponding scores are:
- Loss of smell or taste: 8 points.
- Post-exertional malaise: 7 points.
- Chronic cough: 4 points.
- Brain fog: 3 points.
- Thirst: 3 points.
- Heart palpitations: 2 points.
- Chest pain: 2 points.
- Fatigue: 1 point.
- Dizziness: 1 point.
- Gastrointestinal symptoms: 1 point.
- Issues with sexual desire or capacity: 1 point.
- Abnormal movements (including tremors, slowed movements, rigidity, or sudden, unintended and uncontrollable jerky movements): 1 point.
In general, the higher someone’s score was, the worse their ability to carry out every day activities, said Tanayott Thaweethai, study lead author and researcher at Massachusetts General Hospital and Harvard Medical School. Higher symptom scores also correlated with a lower quality of life, he said.
The country’s treatment of the elderly and patients with comorbidities such as obesity was especially appalling.
“Many elderly people were administered morphine instead of oxygen despite available supplies, effectively ending their lives,” the researchers wrote. “Potentially life-saving treatment was withheld without medical examination, and without informing the patient or his/her family or asking permission.”
In densely populated Stockholm, triage rules stated that patients with comorbidities were not to be admitted to intensive care units, on grounds that they were “unlikely to recover,” the researchers wrote, citing Swedish health strategy documents and statistics from research studies indicating that ICU admissions were biased against older patients.
The Nature authors show that Swedish government authorities denied or downplayed scientific findings about COVID that should have guided them to more reasoned and appropriate policies.
These included scientific findings that infected but asymptomatic or pre-symptomatic people could spread the virus, that it was airborne, that the virus was a greater health threat than the flu and that children were not immune.
The Swedish policymakers “denied or downgraded the fact that children could be infectious, develop severe disease, or drive the spread of the infection in the population,” the Nature authors observe. At the same time, they found, the authorities’ “internal emails indicate their aim to use children to spread the infection in society.”
While a universal coronavirus vaccine is a harder problem to solve than developing a vaccine for one specific variant, the benefits would also be large. If people were already vaccinated with a universal vaccine, we could limit the damage of a new variant even before it took off. Not everyone would be willing to take the universal coronavirus vaccines, but many would; roughly half of the American population took the first Covid-19 booster. What’s more, a universal vaccine could be stockpiled for those who are only likely to want it when a variant emerges, dramatically speeding up the response compared to starting the process of development when a new variant hits.
How much would it cost? We estimate that if the federal government made an advanced market commitment — a legally binding commitment to buy something if it is invented — to purchase enough universal coronavirus vaccine to vaccinate 33% of the American population, it would cost on the order of $5 billion and save the U.S. approximately $700 billion to $1 trillion.
The investment risks are relatively low. If a vaccine does not meet the target product profile for a universal coronavirus vaccine set out by the government, the government wastes no money. If it is met, we protect ourselves in advance against a very real public health threat.
So, what can we do to protect ourselves? Unfortunately, we can’t leave it to private companies to make the investments we need. The economic, health, and education benefits to society from an innovative vaccine are hundreds or even thousands of times more than the revenue to a company from the vaccine. This leads to market failures and, as a result, inadequate innovation.
Amazingly, nobody has been prosecuted. Not sure if anyone's been fired from these govt. jobs.
Sweden didn't have higher death rates and other complications from covid?That is probably because your/LA Times report or the summary in Nature does not seem to have any basis in reality.
Although I remember a study showing that people who wore glasses tended to have lower rates of infection in the Wuhan outbreak.The perspex screens are a foolish idea in any case. It's an airborne virus and screens only reduce airflow, making it more likely to linger in the air. What we need is ventilation and air filtration as that would have more of an impact on reducing infections of both Covid and other airborne pathogens, of which there are many.
The immunosuppressed have be sacrificed at the altar of normality and there will continue to be a significant number of deaths and Long Covid cases in the highest at risk groups. Places such as cancer clinics should really be doubling down on the filtration, ventilation and masking but they aren't and this will cause significant morbidity.
It will be interesting to see if we get any variants emerging which can (almost) completely evade prior immunity whether from infection, vaccination or 'hybrid'. It looks as though the next round of boosters will be monovalent, probably based on XBB.1.5, and this will hopefully prove quite effective at protection of those most at risk. Unfortunately, those who are unable to mount much of an immune response to the vaccines are shit out of luck, because that's the only concession governments are willing to make to them.